Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments

Fig. 1

The expression of PKP1/2/3 mRNA in OV and correlation between PKP1/2/3 expression and tumor stages in OV (Oncomine and GEPIA). a The expression of PKP1/2/3 in ovarian cancer explored by Oncomine database. b–d The mRNA expression of PKP1 (b), PKP2 (c) and PKP3 (d) in OV and normal tissues from GEPIA dataset. e–g The mRNA expression of PKP1 (e), PKP2 (f) and PKP3 (g) in different tumor stages in patients with OV in GEPIA dataset. *P < 0.05, indicating that the results are statistically significant. **P < 0.01, ***P < 0.001. PKP plakophilin, OV Ovarian serous cystadenocarcinoma, GEPIA Gene Expression Profiling Interactive Analysis

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us